Our advisory board consists of 4 international experts.
The HARMLESS advisory board is a group of renowned researchers and professionals from relevant areas who meet regularly with the consortium throughout the project. They support and advise the consortium on all scientific issues, on ethics and on exploitation and dissemination of results.
Wan-Seob Cho
Lab of Toxicology, Department of Medicinal Biotechnology
College of Health Sciences, Dong-A University, Busan, Republic of Korea
Role in the project: Scientific Advisor
Expertise: Nano-related toxicity, exposure, risk, nanosafety and safe-by-design strategies, regulatory perspective
Philip Demokritou
Harvard University, and Rutgers Biomedical Health Sciences
HSPH Center for Nanotechnology and Nanotoxicology
Harvard-NIEHS Nanosafety Research Center
Role in the project: Scientific Advisor; Provision of NM for 1 case study
Expertise: Nanotoxicology, Public Health, NAM technologies, exposure vs. dose modelling
Sabina Halappanavar
Research Scientist, Environmental Health Science and Research Bureau Canada, Health Canada, Ottawa, Canada
Adjunct Professor, Department of Biology – University of Ottawa, Canada
Role in the project: Scientific Advisor
Expertise: Nanotoxicology, Adverse Outcome Pathways, Toxicogenomics, Novel Approach Methodologies
Annie Jarabek
Health and Environmental Effects Assessment Division
Center for Public Health and Environmental Assessment (CPHEA)
Office of Research and Development
U.S. Environmental Protection Agency (US-EPA)
Role in the project: Scientific Advisor
Expertise: Human health risk assessment approaches, Inhalation dosimetry modelling and toxicology, Evidence integration and extrapolation, regulatory applications